SlideShare una empresa de Scribd logo

LGM Pharma - Active Pharmaceutical Ingredient Supplier

•Descargar como PPT, PDF•
•
LGM Pharma
LGM Pharma

LGM Pharma is an API supplier established in 2004 and headquartered in Boca Raton, Florida. It supplies novel APIs globally to support drug research and development. It has a diverse customer base including academic/research institutes, regulatory agencies, biotech/pharma companies. LGM participates in international exhibitions to stay aware of market trends and ensure competitive pricing and product availability for clients. Quality assurance is the top priority, with proper knowledge of regulations and certifications. Therapeutic classifications of APIs include anti-asthma, anti-bacterial, anti-diabetic, and others.

Salud y medicinaEmpresarialesNoticias y política
1 de 11
A CTIVE P HARMACEUTICAL I NGREDIENTS Supplying Novel Active Pharmaceutical Ingredients Today, For Tomorrow’s Innovative Drug Therapies
COMPANY OVERVIEW ,[object Object],[object Object],[object Object],[object Object],[object Object]
OUR CUSTOMERS ,[object Object],[object Object],[object Object],[object Object],[object Object]
RESEARCH & DEVELOPMENT ,[object Object],[object Object],[object Object]
LOGISTIC CAPABILITIES ,[object Object],[object Object],[object Object],[object Object],[object Object]
INTERNATIONAL EXHIBITIONS ,[object Object]
QUALITY ASSURANCE ,[object Object],[object Object],[object Object],[object Object],[object Object]
THERAPEUTIC CLASSIFICATIONS Anti-Asthma Anti-Bacterial Antibiotic Anti-Diabetic Anti-Fungal Anti-Hyperlipodemic Anti-Hypertensive Anti-Migraine Anti-Obesity Anti-Retroviral / Anti-HIV Anti-Thrombotic Chemotherapeutic / Anti-Neoplastic Gliptins Immunosuppressant Monoclonal Antibody (mAb) Prostaglandin Synthetic Peptide
[object Object],In continuation with our efforts to supply only the finest quality to our clients, while minimizing any regulatory problems and quality issues, LGM Pharma has been selected (in Aug 2009) as the sole distributor of Teva for their extensive API portfolio.
COMPOUNDING EXPERIENCE ,[object Object],[object Object],[object Object],[object Object],[object Object]
A CTIVE P HARMACEUTICAL I NGREDIENTS Supplying Novel Active Pharmaceutical Ingredients Today, For Tomorrow’s Innovative Drug Therapies

Recomendados

Sai pharma solutions inc scientific-regulatory affairs-qms and c gmp consult...
Sai pharma solutions inc scientific-regulatory affairs-qms and c gmp consult...Sai pharma solutions inc scientific-regulatory affairs-qms and c gmp consult...
Sai pharma solutions inc scientific-regulatory affairs-qms and c gmp consult...JRamniwas
 
Ron Piervincenzi: "USP Standards: Facilitating a fair and competitive marketp...
Ron Piervincenzi: "USP Standards: Facilitating a fair and competitive marketp...Ron Piervincenzi: "USP Standards: Facilitating a fair and competitive marketp...
Ron Piervincenzi: "USP Standards: Facilitating a fair and competitive marketp...The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics
 
Best Practices - Injectable Packaging Lines
Best Practices - Injectable Packaging LinesBest Practices - Injectable Packaging Lines
Best Practices - Injectable Packaging LinesManish Bhatkar
 
Pharmaceuticals industry
Pharmaceuticals industryPharmaceuticals industry
Pharmaceuticals industryArpit Sem
 
Pharma regulatory affairs
Pharma regulatory affairsPharma regulatory affairs
Pharma regulatory affairsRafat Abedi (IGMPI)
 
Food allergy pipeline review, h1 2015
Food allergy pipeline review, h1 2015Food allergy pipeline review, h1 2015
Food allergy pipeline review, h1 2015Ambikabasa
 
Regulatory affairs in Pharmaceutical Industry
Regulatory affairs in Pharmaceutical IndustryRegulatory affairs in Pharmaceutical Industry
Regulatory affairs in Pharmaceutical IndustryRama Shukla
 
Regulatory affairs
Regulatory affairsRegulatory affairs
Regulatory affairsDipak Bhingardeve
 

Recomendados

Sai pharma solutions inc scientific-regulatory affairs-qms and c gmp consult...
Sai pharma solutions inc scientific-regulatory affairs-qms and c gmp consult...Sai pharma solutions inc scientific-regulatory affairs-qms and c gmp consult...
Sai pharma solutions inc scientific-regulatory affairs-qms and c gmp consult...JRamniwas
 
Ron Piervincenzi: "USP Standards: Facilitating a fair and competitive marketp...
Ron Piervincenzi: "USP Standards: Facilitating a fair and competitive marketp...Ron Piervincenzi: "USP Standards: Facilitating a fair and competitive marketp...
Ron Piervincenzi: "USP Standards: Facilitating a fair and competitive marketp...The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics
 
Best Practices - Injectable Packaging Lines
Best Practices - Injectable Packaging LinesBest Practices - Injectable Packaging Lines
Best Practices - Injectable Packaging LinesManish Bhatkar
 
Pharmaceuticals industry
Pharmaceuticals industryPharmaceuticals industry
Pharmaceuticals industryArpit Sem
 
Pharma regulatory affairs
Pharma regulatory affairsPharma regulatory affairs
Pharma regulatory affairsRafat Abedi (IGMPI)
 
Food allergy pipeline review, h1 2015
Food allergy pipeline review, h1 2015Food allergy pipeline review, h1 2015
Food allergy pipeline review, h1 2015Ambikabasa
 
Regulatory affairs in Pharmaceutical Industry
Regulatory affairs in Pharmaceutical IndustryRegulatory affairs in Pharmaceutical Industry
Regulatory affairs in Pharmaceutical IndustryRama Shukla
 
Regulatory affairs
Regulatory affairsRegulatory affairs
Regulatory affairsDipak Bhingardeve
 
Eu and usa key differences 1
Eu and usa key differences 1Eu and usa key differences 1
Eu and usa key differences 1Ann McGee
 
Regulatory Affairs Profession
Regulatory Affairs ProfessionRegulatory Affairs Profession
Regulatory Affairs ProfessionInstitute of Pharmaceutical Management
 
"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER
"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER
"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLERBiocat, BioRegion of Catalonia
 
Future Pharma Trends - Long-term opportunities tempered by short-term challenges
Future Pharma Trends - Long-term opportunities tempered by short-term challengesFuture Pharma Trends - Long-term opportunities tempered by short-term challenges
Future Pharma Trends - Long-term opportunities tempered by short-term challengesscottosur
 
China Excipients Regulation Overview
China Excipients Regulation OverviewChina Excipients Regulation Overview
China Excipients Regulation OverviewMerck Life Sciences
 
Emphysema pipeline review, h1 2015
Emphysema pipeline review, h1 2015Emphysema pipeline review, h1 2015
Emphysema pipeline review, h1 2015Ambikabasa
 
Introduction to Regulatory Affairs - Pauwels Consulting Academy
Introduction to Regulatory Affairs - Pauwels Consulting AcademyIntroduction to Regulatory Affairs - Pauwels Consulting Academy
Introduction to Regulatory Affairs - Pauwels Consulting AcademyPauwels Consulting
 
Regulatory affairs by bishnu koirala
Regulatory affairs by bishnu koiralaRegulatory affairs by bishnu koirala
Regulatory affairs by bishnu koiralaBishnu Koirala
 
Overcoming process development and biologics manufacturing challenges
Overcoming process development and biologics manufacturing challengesOvercoming process development and biologics manufacturing challenges
Overcoming process development and biologics manufacturing challengesMaRS Discovery District
 
Raaj Global Pharma Regulatory Affairs Consultants Thane-mumbai profile-updat...
Raaj Global Pharma Regulatory Affairs Consultants Thane-mumbai profile-updat...Raaj Global Pharma Regulatory Affairs Consultants Thane-mumbai profile-updat...
Raaj Global Pharma Regulatory Affairs Consultants Thane-mumbai profile-updat...Rajashri Survase Ojha
 
Eye & Ear Drop by Alna Biotech Private Limited Chandigarh
Eye & Ear Drop by Alna Biotech Private Limited ChandigarhEye & Ear Drop by Alna Biotech Private Limited Chandigarh
Eye & Ear Drop by Alna Biotech Private Limited ChandigarhIndiaMART InterMESH Limited
 
FAsTEST
FAsTESTFAsTEST
FAsTESTDavide Cilano
 
Future supply chains for the pharmaceutical industry – a collaborative approach
Future supply chains for the pharmaceutical industry – a collaborative approachFuture supply chains for the pharmaceutical industry – a collaborative approach
Future supply chains for the pharmaceutical industry – a collaborative approachEuropean Industrial Pharmacists Group
 
Drug Regulatory Affairs
Drug Regulatory AffairsDrug Regulatory Affairs
Drug Regulatory AffairsNamdeo Shinde
 
Regulatory Due Diligence, Using Regulatory Affairs to Maximize the Value of a...
Regulatory Due Diligence, Using Regulatory Affairs to Maximize the Value of a...Regulatory Due Diligence, Using Regulatory Affairs to Maximize the Value of a...
Regulatory Due Diligence, Using Regulatory Affairs to Maximize the Value of a...SGS
 
EU and US Procedures for API Registration - Commonalities and Differences
EU and US Procedures for API Registration - Commonalities and DifferencesEU and US Procedures for API Registration - Commonalities and Differences
EU and US Procedures for API Registration - Commonalities and DifferencesMerck Life Sciences
 
Who good distributionpracticesforpharmaceuticalproducts
Who good distributionpracticesforpharmaceuticalproductsWho good distributionpracticesforpharmaceuticalproducts
Who good distributionpracticesforpharmaceuticalproductsadeelzia84
 
Pharmaceutical Regulaions; Emergence & Complexity
Pharmaceutical Regulaions; Emergence & ComplexityPharmaceutical Regulaions; Emergence & Complexity
Pharmaceutical Regulaions; Emergence & ComplexityObaid Ali / Roohi B. Obaid
 
Present industry expectations from pharmacy students
Present industry expectations from pharmacy studentsPresent industry expectations from pharmacy students
Present industry expectations from pharmacy studentsMalay Singh
 
Several types of pharmaceutical companies serving the industry
Several types of pharmaceutical companies serving the industrySeveral types of pharmaceutical companies serving the industry
Several types of pharmaceutical companies serving the industryStuSilverman
 
Introduction to Android development - Presentation
Introduction to Android development - PresentationIntroduction to Android development - Presentation
Introduction to Android development - PresentationAtul Panjwani
 
SAP BOBJ Rapid Marts Overview I
SAP BOBJ Rapid Marts Overview ISAP BOBJ Rapid Marts Overview I
SAP BOBJ Rapid Marts Overview IRamakrishna Kamurthy
 

Más contenido relacionado

La actualidad más candente

Eu and usa key differences 1
Eu and usa key differences 1Eu and usa key differences 1
Eu and usa key differences 1Ann McGee
 
"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER
"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER
"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLERBiocat, BioRegion of Catalonia
 
Future Pharma Trends - Long-term opportunities tempered by short-term challenges
Future Pharma Trends - Long-term opportunities tempered by short-term challengesFuture Pharma Trends - Long-term opportunities tempered by short-term challenges
Future Pharma Trends - Long-term opportunities tempered by short-term challengesscottosur
 
China Excipients Regulation Overview
China Excipients Regulation OverviewChina Excipients Regulation Overview
China Excipients Regulation OverviewMerck Life Sciences
 
Emphysema pipeline review, h1 2015
Emphysema pipeline review, h1 2015Emphysema pipeline review, h1 2015
Emphysema pipeline review, h1 2015Ambikabasa
 
Introduction to Regulatory Affairs - Pauwels Consulting Academy
Introduction to Regulatory Affairs - Pauwels Consulting AcademyIntroduction to Regulatory Affairs - Pauwels Consulting Academy
Introduction to Regulatory Affairs - Pauwels Consulting AcademyPauwels Consulting
 
Regulatory affairs by bishnu koirala
Regulatory affairs by bishnu koiralaRegulatory affairs by bishnu koirala
Regulatory affairs by bishnu koiralaBishnu Koirala
 
Overcoming process development and biologics manufacturing challenges
Overcoming process development and biologics manufacturing challengesOvercoming process development and biologics manufacturing challenges
Overcoming process development and biologics manufacturing challengesMaRS Discovery District
 
Raaj Global Pharma Regulatory Affairs Consultants Thane-mumbai profile-updat...
Raaj Global Pharma Regulatory Affairs Consultants Thane-mumbai profile-updat...Raaj Global Pharma Regulatory Affairs Consultants Thane-mumbai profile-updat...
Raaj Global Pharma Regulatory Affairs Consultants Thane-mumbai profile-updat...Rajashri Survase Ojha
 
Eye & Ear Drop by Alna Biotech Private Limited Chandigarh
Eye & Ear Drop by Alna Biotech Private Limited ChandigarhEye & Ear Drop by Alna Biotech Private Limited Chandigarh
Eye & Ear Drop by Alna Biotech Private Limited ChandigarhIndiaMART InterMESH Limited
 
Future supply chains for the pharmaceutical industry – a collaborative approach
Future supply chains for the pharmaceutical industry – a collaborative approachFuture supply chains for the pharmaceutical industry – a collaborative approach
Future supply chains for the pharmaceutical industry – a collaborative approachEuropean Industrial Pharmacists Group
 
Drug Regulatory Affairs
Drug Regulatory AffairsDrug Regulatory Affairs
Drug Regulatory AffairsNamdeo Shinde
 
Regulatory Due Diligence, Using Regulatory Affairs to Maximize the Value of a...
Regulatory Due Diligence, Using Regulatory Affairs to Maximize the Value of a...Regulatory Due Diligence, Using Regulatory Affairs to Maximize the Value of a...
Regulatory Due Diligence, Using Regulatory Affairs to Maximize the Value of a...SGS
 
EU and US Procedures for API Registration - Commonalities and Differences
EU and US Procedures for API Registration - Commonalities and DifferencesEU and US Procedures for API Registration - Commonalities and Differences
EU and US Procedures for API Registration - Commonalities and DifferencesMerck Life Sciences
 
Who good distributionpracticesforpharmaceuticalproducts
Who good distributionpracticesforpharmaceuticalproductsWho good distributionpracticesforpharmaceuticalproducts
Who good distributionpracticesforpharmaceuticalproductsadeelzia84
 
Pharmaceutical Regulaions; Emergence & Complexity
Pharmaceutical Regulaions; Emergence & ComplexityPharmaceutical Regulaions; Emergence & Complexity
Pharmaceutical Regulaions; Emergence & ComplexityObaid Ali / Roohi B. Obaid
 
Present industry expectations from pharmacy students
Present industry expectations from pharmacy studentsPresent industry expectations from pharmacy students
Present industry expectations from pharmacy studentsMalay Singh
 
Several types of pharmaceutical companies serving the industry
Several types of pharmaceutical companies serving the industrySeveral types of pharmaceutical companies serving the industry
Several types of pharmaceutical companies serving the industryStuSilverman
 

La actualidad más candente (20)

Eu and usa key differences 1
Eu and usa key differences 1Eu and usa key differences 1
Eu and usa key differences 1
 
Regulatory Affairs Profession
Regulatory Affairs ProfessionRegulatory Affairs Profession
Regulatory Affairs Profession
 
"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER
"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER
"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER
 
Future Pharma Trends - Long-term opportunities tempered by short-term challenges
Future Pharma Trends - Long-term opportunities tempered by short-term challengesFuture Pharma Trends - Long-term opportunities tempered by short-term challenges
Future Pharma Trends - Long-term opportunities tempered by short-term challenges
 
China Excipients Regulation Overview
China Excipients Regulation OverviewChina Excipients Regulation Overview
China Excipients Regulation Overview
 
Emphysema pipeline review, h1 2015
Emphysema pipeline review, h1 2015Emphysema pipeline review, h1 2015
Emphysema pipeline review, h1 2015
 
Introduction to Regulatory Affairs - Pauwels Consulting Academy
Introduction to Regulatory Affairs - Pauwels Consulting AcademyIntroduction to Regulatory Affairs - Pauwels Consulting Academy
Introduction to Regulatory Affairs - Pauwels Consulting Academy
 
Regulatory affairs by bishnu koirala
Regulatory affairs by bishnu koiralaRegulatory affairs by bishnu koirala
Regulatory affairs by bishnu koirala
 
Overcoming process development and biologics manufacturing challenges
Overcoming process development and biologics manufacturing challengesOvercoming process development and biologics manufacturing challenges
Overcoming process development and biologics manufacturing challenges
 
Raaj Global Pharma Regulatory Affairs Consultants Thane-mumbai profile-updat...
Raaj Global Pharma Regulatory Affairs Consultants Thane-mumbai profile-updat...Raaj Global Pharma Regulatory Affairs Consultants Thane-mumbai profile-updat...
Raaj Global Pharma Regulatory Affairs Consultants Thane-mumbai profile-updat...
 
Eye & Ear Drop by Alna Biotech Private Limited Chandigarh
Eye & Ear Drop by Alna Biotech Private Limited ChandigarhEye & Ear Drop by Alna Biotech Private Limited Chandigarh
Eye & Ear Drop by Alna Biotech Private Limited Chandigarh
 
FAsTEST
FAsTESTFAsTEST
FAsTEST
 
Future supply chains for the pharmaceutical industry – a collaborative approach
Future supply chains for the pharmaceutical industry – a collaborative approachFuture supply chains for the pharmaceutical industry – a collaborative approach
Future supply chains for the pharmaceutical industry – a collaborative approach
 
Drug Regulatory Affairs
Drug Regulatory AffairsDrug Regulatory Affairs
Drug Regulatory Affairs
 
Regulatory Due Diligence, Using Regulatory Affairs to Maximize the Value of a...
Regulatory Due Diligence, Using Regulatory Affairs to Maximize the Value of a...Regulatory Due Diligence, Using Regulatory Affairs to Maximize the Value of a...
Regulatory Due Diligence, Using Regulatory Affairs to Maximize the Value of a...
 
EU and US Procedures for API Registration - Commonalities and Differences
EU and US Procedures for API Registration - Commonalities and DifferencesEU and US Procedures for API Registration - Commonalities and Differences
EU and US Procedures for API Registration - Commonalities and Differences
 
Who good distributionpracticesforpharmaceuticalproducts
Who good distributionpracticesforpharmaceuticalproductsWho good distributionpracticesforpharmaceuticalproducts
Who good distributionpracticesforpharmaceuticalproducts
 
Pharmaceutical Regulaions; Emergence & Complexity
Pharmaceutical Regulaions; Emergence & ComplexityPharmaceutical Regulaions; Emergence & Complexity
Pharmaceutical Regulaions; Emergence & Complexity
 
Present industry expectations from pharmacy students
Present industry expectations from pharmacy studentsPresent industry expectations from pharmacy students
Present industry expectations from pharmacy students
 
Several types of pharmaceutical companies serving the industry
Several types of pharmaceutical companies serving the industrySeveral types of pharmaceutical companies serving the industry
Several types of pharmaceutical companies serving the industry
 

Destacado

Introduction to Android development - Presentation
Introduction to Android development - PresentationIntroduction to Android development - Presentation
Introduction to Android development - PresentationAtul Panjwani
 
COST ALLOCATION, CUSTOMER-PROFITABILITY
COST ALLOCATION, CUSTOMER-PROFITABILITY COST ALLOCATION, CUSTOMER-PROFITABILITY
COST ALLOCATION, CUSTOMER-PROFITABILITY Babasab Patil
 
Statragic controlling
Statragic controllingStatragic controlling
Statragic controllingducanh2003
 
Trang thong-tin-the-agribank-so-2 thang-1.2012
Trang thong-tin-the-agribank-so-2 thang-1.2012Trang thong-tin-the-agribank-so-2 thang-1.2012
Trang thong-tin-the-agribank-so-2 thang-1.2012ducanh2003
 
Financial Institution_Market Data Cost Allocation
Financial Institution_Market Data Cost AllocationFinancial Institution_Market Data Cost Allocation
Financial Institution_Market Data Cost AllocationBurak S. Arikan
 
LGM Pharma Synthetic Peptides
LGM Pharma Synthetic PeptidesLGM Pharma Synthetic Peptides
LGM Pharma Synthetic PeptidesLGM Pharma
 
LGM Pharma | Drug Research & Development APIs
LGM Pharma | Drug Research & Development APIsLGM Pharma | Drug Research & Development APIs
LGM Pharma | Drug Research & Development APIsLGM Pharma
 
Controlling management
Controlling managementControlling management
Controlling managementbadityaa
 
Dublin City Manager's Presenation to Dublin Chamber
Dublin City Manager's Presenation to Dublin Chamber Dublin City Manager's Presenation to Dublin Chamber
Dublin City Manager's Presenation to Dublin Chamber Dublin Chamber of Commerce
 
The Healthy Picture Life Science Quo Vadis (Thomas Cueni)
The Healthy Picture Life Science Quo Vadis (Thomas Cueni)The Healthy Picture Life Science Quo Vadis (Thomas Cueni)
The Healthy Picture Life Science Quo Vadis (Thomas Cueni)Zaki Sellam
 
Ksvb Execute Plan Cost Distribution
Ksvb Execute Plan Cost DistributionKsvb Execute Plan Cost Distribution
Ksvb Execute Plan Cost Distributionwhocanbe1
 
Xyberspace Consulting Case Analysis
Xyberspace Consulting Case AnalysisXyberspace Consulting Case Analysis
Xyberspace Consulting Case AnalysisMarc Upchurch, MBA
 
performance appraisal form of singer
performance appraisal form of singerperformance appraisal form of singer
performance appraisal form of singerShohanuzzaman somudro
 

Destacado (20)

Introduction to Android development - Presentation
Introduction to Android development - PresentationIntroduction to Android development - Presentation
Introduction to Android development - Presentation
 
SAP BOBJ Rapid Marts Overview I
SAP BOBJ Rapid Marts Overview ISAP BOBJ Rapid Marts Overview I
SAP BOBJ Rapid Marts Overview I
 
COST ALLOCATION, CUSTOMER-PROFITABILITY
COST ALLOCATION, CUSTOMER-PROFITABILITY COST ALLOCATION, CUSTOMER-PROFITABILITY
COST ALLOCATION, CUSTOMER-PROFITABILITY
 
Statragic controlling
Statragic controllingStatragic controlling
Statragic controlling
 
Trang thong-tin-the-agribank-so-2 thang-1.2012
Trang thong-tin-the-agribank-so-2 thang-1.2012Trang thong-tin-the-agribank-so-2 thang-1.2012
Trang thong-tin-the-agribank-so-2 thang-1.2012
 
Financial Institution_Market Data Cost Allocation
Financial Institution_Market Data Cost AllocationFinancial Institution_Market Data Cost Allocation
Financial Institution_Market Data Cost Allocation
 
LGM Pharma Synthetic Peptides
LGM Pharma Synthetic PeptidesLGM Pharma Synthetic Peptides
LGM Pharma Synthetic Peptides
 
LGM Pharma | Drug Research & Development APIs
LGM Pharma | Drug Research & Development APIsLGM Pharma | Drug Research & Development APIs
LGM Pharma | Drug Research & Development APIs
 
NOVOSci Breif Presentation
NOVOSci Breif PresentationNOVOSci Breif Presentation
NOVOSci Breif Presentation
 
ReImagine BI – ElegantJ BI
ReImagine BI – ElegantJ BIReImagine BI – ElegantJ BI
ReImagine BI – ElegantJ BI
 
Business Intelligence for BRTS
Business Intelligence for BRTSBusiness Intelligence for BRTS
Business Intelligence for BRTS
 
ElegantJ BI Overview
ElegantJ BI OverviewElegantJ BI Overview
ElegantJ BI Overview
 
Heat transfer
Heat transferHeat transfer
Heat transfer
 
Controlling management
Controlling managementControlling management
Controlling management
 
Dublin City Manager's Presenation to Dublin Chamber
Dublin City Manager's Presenation to Dublin Chamber Dublin City Manager's Presenation to Dublin Chamber
Dublin City Manager's Presenation to Dublin Chamber
 
The Healthy Picture Life Science Quo Vadis (Thomas Cueni)
The Healthy Picture Life Science Quo Vadis (Thomas Cueni)The Healthy Picture Life Science Quo Vadis (Thomas Cueni)
The Healthy Picture Life Science Quo Vadis (Thomas Cueni)
 
Ksvb Execute Plan Cost Distribution
Ksvb Execute Plan Cost DistributionKsvb Execute Plan Cost Distribution
Ksvb Execute Plan Cost Distribution
 
Business Intelligence for Mining
Business Intelligence for MiningBusiness Intelligence for Mining
Business Intelligence for Mining
 
Xyberspace Consulting Case Analysis
Xyberspace Consulting Case AnalysisXyberspace Consulting Case Analysis
Xyberspace Consulting Case Analysis
 
performance appraisal form of singer
performance appraisal form of singerperformance appraisal form of singer
performance appraisal form of singer
 

Similar a LGM Pharma - Active Pharmaceutical Ingredient Supplier

Final supply chain in pharma
Final supply chain in pharmaFinal supply chain in pharma
Final supply chain in pharmaJai Verma
 
International marketing Marketing Decisions on marketing MIX
International marketing Marketing Decisions on marketing MIXInternational marketing Marketing Decisions on marketing MIX
International marketing Marketing Decisions on marketing MIXDhanushka Bandara
 
Cell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval SolutionsCell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval SolutionsCovance
 
TLG Business Plan Presentation
TLG Business Plan PresentationTLG Business Plan Presentation
TLG Business Plan Presentationnroopraj24
 
Fundamental concept of regulatory affairs in pharmaceutical & biotechnology
Fundamental concept of regulatory affairs in pharmaceutical & biotechnologyFundamental concept of regulatory affairs in pharmaceutical & biotechnology
Fundamental concept of regulatory affairs in pharmaceutical & biotechnologyHitendra Singh
 
The 10 Most Innovative Pharma and Biotech Solution Providers, 2020 September ...
The 10 Most Innovative Pharma and Biotech Solution Providers, 2020 September ...The 10 Most Innovative Pharma and Biotech Solution Providers, 2020 September ...
The 10 Most Innovative Pharma and Biotech Solution Providers, 2020 September ...Merry D'souza
 
SABIC-Healthcare-Brochure-2019_tcm1010-21230.pdf
SABIC-Healthcare-Brochure-2019_tcm1010-21230.pdfSABIC-Healthcare-Brochure-2019_tcm1010-21230.pdf
SABIC-Healthcare-Brochure-2019_tcm1010-21230.pdfmalek12
 
NARCOTIC ANAGETIC DRUG AHMEDABAD
NARCOTIC ANAGETIC DRUG AHMEDABADNARCOTIC ANAGETIC DRUG AHMEDABAD
NARCOTIC ANAGETIC DRUG AHMEDABADjitharadharmesh
 
Innovotech Investor Presentation December 1, 2010
Innovotech Investor Presentation December 1, 2010Innovotech Investor Presentation December 1, 2010
Innovotech Investor Presentation December 1, 2010Innovotech Inc.
 
18th pharmacovigilance 2019
18th pharmacovigilance 201918th pharmacovigilance 2019
18th pharmacovigilance 2019Dinesh T
 
Cell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise SolutionsCell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise SolutionsCovance
 
Presentation20190103 final
Presentation20190103 finalPresentation20190103 final
Presentation20190103 finalWayne Wei
 
SWAPNROOP DRUGS AND PHARMACEUTICALS
SWAPNROOP DRUGS AND PHARMACEUTICALSSWAPNROOP DRUGS AND PHARMACEUTICALS
SWAPNROOP DRUGS AND PHARMACEUTICALSAPI MANUFACTURER
 
Cell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise SolutionsCell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise SolutionsCovance
 
Pharma Focus Asia Issue 21
Pharma Focus Asia Issue 21Pharma Focus Asia Issue 21
Pharma Focus Asia Issue 21yahyasultan
 

Similar a LGM Pharma - Active Pharmaceutical Ingredient Supplier (20)

Final supply chain in pharma
Final supply chain in pharmaFinal supply chain in pharma
Final supply chain in pharma
 
Progamma Us
Progamma UsProgamma Us
Progamma Us
 
Bhavna final
Bhavna finalBhavna final
Bhavna final
 
International marketing Marketing Decisions on marketing MIX
International marketing Marketing Decisions on marketing MIXInternational marketing Marketing Decisions on marketing MIX
International marketing Marketing Decisions on marketing MIX
 
Alpha MD
Alpha MDAlpha MD
Alpha MD
 
Cell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval SolutionsCell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval Solutions
 
Biosimilar Dug Development
Biosimilar Dug DevelopmentBiosimilar Dug Development
Biosimilar Dug Development
 
TLG Business Plan Presentation
TLG Business Plan PresentationTLG Business Plan Presentation
TLG Business Plan Presentation
 
Blog april2016 companycreation
Blog april2016 companycreationBlog april2016 companycreation
Blog april2016 companycreation
 
Fundamental concept of regulatory affairs in pharmaceutical & biotechnology
Fundamental concept of regulatory affairs in pharmaceutical & biotechnologyFundamental concept of regulatory affairs in pharmaceutical & biotechnology
Fundamental concept of regulatory affairs in pharmaceutical & biotechnology
 
The 10 Most Innovative Pharma and Biotech Solution Providers, 2020 September ...
The 10 Most Innovative Pharma and Biotech Solution Providers, 2020 September ...The 10 Most Innovative Pharma and Biotech Solution Providers, 2020 September ...
The 10 Most Innovative Pharma and Biotech Solution Providers, 2020 September ...
 
SABIC-Healthcare-Brochure-2019_tcm1010-21230.pdf
SABIC-Healthcare-Brochure-2019_tcm1010-21230.pdfSABIC-Healthcare-Brochure-2019_tcm1010-21230.pdf
SABIC-Healthcare-Brochure-2019_tcm1010-21230.pdf
 
NARCOTIC ANAGETIC DRUG AHMEDABAD
NARCOTIC ANAGETIC DRUG AHMEDABADNARCOTIC ANAGETIC DRUG AHMEDABAD
NARCOTIC ANAGETIC DRUG AHMEDABAD
 
Innovotech Investor Presentation December 1, 2010
Innovotech Investor Presentation December 1, 2010Innovotech Investor Presentation December 1, 2010
Innovotech Investor Presentation December 1, 2010
 
18th pharmacovigilance 2019
18th pharmacovigilance 201918th pharmacovigilance 2019
18th pharmacovigilance 2019
 
Cell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise SolutionsCell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise Solutions
 
Presentation20190103 final
Presentation20190103 finalPresentation20190103 final
Presentation20190103 final
 
SWAPNROOP DRUGS AND PHARMACEUTICALS
SWAPNROOP DRUGS AND PHARMACEUTICALSSWAPNROOP DRUGS AND PHARMACEUTICALS
SWAPNROOP DRUGS AND PHARMACEUTICALS
 
Cell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise SolutionsCell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise Solutions
 
Pharma Focus Asia Issue 21
Pharma Focus Asia Issue 21Pharma Focus Asia Issue 21
Pharma Focus Asia Issue 21
 

Último

180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghanahealthwatchghana
 
Pharmacology of drugs acting on Renal System.pdf
Pharmacology of drugs acting on Renal System.pdfPharmacology of drugs acting on Renal System.pdf
Pharmacology of drugs acting on Renal System.pdfAFFIFA HUSSAIN
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...Ayman Seddik
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationMedicoseAcademics
 
Sonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptxSonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptxpalsonia139
 
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالةGallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالةMohamad محمد Al-Gailani الكيلاني
 
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerCas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerSherrylee83
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxSergio Pinski
 
hypo and hyper thyroidism final lecture.pptx
hypo and hyper thyroidism final lecture.pptxhypo and hyper thyroidism final lecture.pptx
hypo and hyper thyroidism final lecture.pptxdr shahida
 
Mgr university bsc nursing adult health previous question paper with answers
Mgr university bsc nursing adult health previous question paper with answersMgr university bsc nursing adult health previous question paper with answers
Mgr university bsc nursing adult health previous question paper with answersShafnaP5
 
World Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 pptWorld Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 pptdesktoppc
 
Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)Cancer Institute NSW
 
TEST BANK for Wilkins’ Clinical Assessment in Respiratory Care, 9th Edition b...
TEST BANK for Wilkins’ Clinical Assessment in Respiratory Care, 9th Edition b...TEST BANK for Wilkins’ Clinical Assessment in Respiratory Care, 9th Edition b...
TEST BANK for Wilkins’ Clinical Assessment in Respiratory Care, 9th Edition b...marcuskenyatta275
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxDr KHALID B.M
 
Factors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryFactors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryDr Simran Deepak Vangani
 
Presentació "Advancing Emergency Medicine Education through Virtual Reality"
Presentació "Advancing Emergency Medicine Education through Virtual Reality"Presentació "Advancing Emergency Medicine Education through Virtual Reality"
Presentació "Advancing Emergency Medicine Education through Virtual Reality"Badalona Serveis Assistencials
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1DR SETH JOTHAM
 
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptxSURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptxSuresh Kumar K
 
Tips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examTips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examJunhao Koh
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadNephroTube - Dr.Gawad
 

Último (20)

180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana
 
Pharmacology of drugs acting on Renal System.pdf
Pharmacology of drugs acting on Renal System.pdfPharmacology of drugs acting on Renal System.pdf
Pharmacology of drugs acting on Renal System.pdf
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
 
Sonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptxSonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptx
 
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالةGallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
 
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerCas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptx
 
hypo and hyper thyroidism final lecture.pptx
hypo and hyper thyroidism final lecture.pptxhypo and hyper thyroidism final lecture.pptx
hypo and hyper thyroidism final lecture.pptx
 
Mgr university bsc nursing adult health previous question paper with answers
Mgr university bsc nursing adult health previous question paper with answersMgr university bsc nursing adult health previous question paper with answers
Mgr university bsc nursing adult health previous question paper with answers
 
World Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 pptWorld Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 ppt
 
Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)
 
TEST BANK for Wilkins’ Clinical Assessment in Respiratory Care, 9th Edition b...
TEST BANK for Wilkins’ Clinical Assessment in Respiratory Care, 9th Edition b...TEST BANK for Wilkins’ Clinical Assessment in Respiratory Care, 9th Edition b...
TEST BANK for Wilkins’ Clinical Assessment in Respiratory Care, 9th Edition b...
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
 
Factors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryFactors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric Dentistry
 
Presentació "Advancing Emergency Medicine Education through Virtual Reality"
Presentació "Advancing Emergency Medicine Education through Virtual Reality"Presentació "Advancing Emergency Medicine Education through Virtual Reality"
Presentació "Advancing Emergency Medicine Education through Virtual Reality"
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
 
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptxSURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
 
Tips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examTips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES exam
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
 

LGM Pharma - Active Pharmaceutical Ingredient Supplier

  • 1. A CTIVE P HARMACEUTICAL I NGREDIENTS Supplying Novel Active Pharmaceutical Ingredients Today, For Tomorrow’s Innovative Drug Therapies
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8. THERAPEUTIC CLASSIFICATIONS Anti-Asthma Anti-Bacterial Antibiotic Anti-Diabetic Anti-Fungal Anti-Hyperlipodemic Anti-Hypertensive Anti-Migraine Anti-Obesity Anti-Retroviral / Anti-HIV Anti-Thrombotic Chemotherapeutic / Anti-Neoplastic Gliptins Immunosuppressant Monoclonal Antibody (mAb) Prostaglandin Synthetic Peptide
  • 9.
  • 10.
  • 11. A CTIVE P HARMACEUTICAL I NGREDIENTS Supplying Novel Active Pharmaceutical Ingredients Today, For Tomorrow’s Innovative Drug Therapies